Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases

被引：0
|
作者：
Wenxiao Jia
Xiaoyang Zhai
Xuquan Jing
Qingdong Bao
Shuhui Xu
Hui Zhu
Gang Wu
Jinming Yu
机构：
[1] Huazhong University of Science and Technology,Cancer Center, Union Hospital, Tongji Medical College
[2] Shandong First Medical University and Shandong Academy of Medical Sciences,Department of Radiation Oncology, Shandong Cancer Hospital and Institute
[3] The First Affiliated Hospital of Shantou University Medical College,Department of Radiation Oncology, Shandong Cancer Hospital, Cheeloo College of Medicine
[4] Shandong University,Eye Institute of Shandong First Medical University
[5] Eye Hospital of Shandong First Medical University (Shandong Eye Hospital),undefined
来源：
Journal of Neuro-Oncology | 2023年 / 164卷 / 2期
关键词：
Lung-molGPA; Cranial radiotherapy; Brain metastases; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 330
页数：9
相关论文
共 50 条
  • [1] Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases
    Jia, Wenxiao
    Zhai, Xiaoyang
    Jing, Xuquan
    Bao, Qingdong
    Xu, Shuhui
    Zhu, Hui
    Wu, Gang
    Yu, Jinming
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 321 - 330
  • [2] Selecting Optimal Timing of Cranial Radiotherapy Based on the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) in Patients with NonSmall Cell Lung Cancer and Brain Metastases
    Zhai, X.
    Li, J.
    Jing, W.
    Jia, W.
    Zhu, H.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E66 - E66
  • [3] Applicability of the Lung-molGPA Index in NSCLC Patients with Different Gene Alterations and Brain Metastases
    Chen, K.
    Yu, X.
    Fan, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1070 - S1070
  • [4] Selecting optimal timing of cranial radiotherapy-based on the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) in patients with non-small cell lung cancer and brain metastases.
    Zhai, Xiaoyang
    Li, Ji
    Jing, Wang
    Jia, Wenxiao
    Zhu, Hui
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] The prognostic value of liver metastases and how affects the applicability of the lung-molGPA in non-small cell lung cancer patients with brain metastases
    Veas Rodriguez, J. R.
    Morales Murillo, S.
    Rodriguez Galindo, A.
    Pallise Subirats, O.
    Cordoba Ortega, J. F.
    ANNALS OF ONCOLOGY, 2021, 32 : S526 - S526
  • [6] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
    Carsten Nieder
    Mandy Hintz
    Oliver Oehlke
    Angelika Bilger
    Anca L. Grosu
    Radiation Oncology, 12
  • [7] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
    Nieder, Carsten
    Hintz, Mandy
    Oehlke, Oliver
    Bilger, Angelika
    Grosu, Anca L.
    RADIATION ONCOLOGY, 2017, 12
  • [8] Effects of different brain radiotherapy strategies based on lung-molGPA stratification on the prognosis of patients with brain metastases of EGFR-mutant lung adenocarcinoma
    Deng, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S979 - S979
  • [9] Targeted therapies and utility of the Lung-molGPA in non-small-cell lung cancer patients with brain metastases
    Cacho-Diaz, Bernardo
    Cuapantecatl, Laura D.
    Garcilazo-Reyes, Ytel J.
    Cabrera-Miranda, Luis
    Hernandez-Martinez, Juan-Manuel
    Arrieta, Oscar
    ONCOLOGY, 2022, 100 (10) : 542 - 554
  • [10] Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
    Sperduto, Paul W.
    Yang, T. Jonathan
    Beal, Kathryn
    Pan, Hubert
    Brown, Paul D.
    Bangdiwala, Ananta
    Shanley, Ryan
    Yeh, Norman
    Gaspar, Laurie E.
    Braunstein, Steve
    Sneed, Penny
    Boyle, John
    Kirkpatrick, John P.
    Mak, Kimberley S.
    Shih, Helen A.
    Engelman, Alex
    Roberge, David
    Arvold, Nils D.
    Alexander, Brian
    Awad, Mark M.
    Contessa, Joseph
    Chiang, Veronica
    Hardie, John
    Ma, Daniel
    Lou, Emil
    Sperduto, William
    Mehta, Minesh P.
    JAMA ONCOLOGY, 2017, 3 (06) : 827 - 831
12345